急性冠脉综合征
OPTIMAL USE OF LIPID-LOWERING THERAPY AFTER ACUTE CORONARY SYNDROMES: A Position Paper endorsed by the International Lipid Expert Panel (ILEP)
M Banach, PE Penson, ACS EuroPath Central & South European Countries Project et al.
Keywords: PCSK9 inhibitors; combination therapy; effectiveness; ezetimibe; safety; statins